Mallinckrodt Plc (New York Stock Exchange:MNK)

About the company

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

3400

CEO

Mark C. Trudeau

Exchange

New York Stock Exchange

Website

http://mallinckrodt.com

$3B

Total Revenue

3K

Employees

$199.08M

Market Capitalization

-0.17

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$1370M

Operating Margin (in %)

Total operating margin

$197M

Net Margin (in %)

Total net margin

$-1201M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7525.41 4837.00 1.29 51.34 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5064.54 1443.00 1.76 9.77 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 3004.40 None 20.39 -33.40 None
Pacira Biosciences, Inc. PCRX 2374.68 435.00 6.37 -5654.00 -0.02
SAGE Therapeutics, Inc. SAGE 2295.80 9.00 2.70 -3.55 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Corcept Therapeutics, Inc. CORT 2043.50 335.00 4.69 19.25 31.64
Prestige Consumer Healthcare, Inc. PBH 1862.52 963.00 1.57 13.14 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1617.30 0.00 4.32 -15.83 -624.74
Revolution Medicines, Inc. RVMD 1581.20 48.00 4.10 -22.33 -146.29
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1539.06 285.00 3.64 7.96 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1272.60 5.00 3.47 -2.99 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1220.94 88.00 -8.57 -4.95 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1020.18 327.00 2.55 20.02 15.90
Endo International Plc ENDP 777.48 3014.00 -1.06 -2.77 -9.09
BellRing Brands, Inc. BRBR 745.68 954.00 -0.40 5.66 13.98
Assembly Biosciences, Inc. ASMB 680.34 16.00 3.05 -6.84 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 616.86 79.00 4.89 -3.05 -252.92
Collegium Pharmaceutical, Inc. COLL 582.76 299.00 4.17 -45.11 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 536.07 119.00 5.22 12.22 36.09
Anika Therapeutics, Inc. ANIK 494.20 125.00 1.71 17.83 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 331.24 11.00 3.37 -4.33 -730.55
MEI Pharma, Inc. MEIP 288.01 5.00 4.96 -7.38 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 161.66 None 2.63 -7.83 None
Marinus Pharmaceuticals, Inc. MRNS 151.20 0.00 5.85 -2.24 None
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.38 1.00 68.80 -5.29 None
Evoke Pharma, Inc. EVOK 85.92 None 29.83 -12.79 None
AcelRx Pharmaceuticals, Inc. ACRX 85.60 2.00 -1.57 -1.53 -644.25
CTI BioPharma Corp. CTIC 83.78 3.00 3.74 -2.03 -111.83
Zynerba Pharmaceuticals, Inc. ZYNE 78.66 0.00 1.29 -2.19 -699.94
Aclaris Therapeutics, Inc. ACRS 73.80 4.00 1.29 -0.54 None
Adamas Pharmaceuticals, Inc. ADMS 70.84 57.00 -4.52 -0.76 -160.44
Oramed Pharmaceuticals, Inc. ORMP 61.02 3.00 4.91 -4.77 -464.15
Cassava Sciences, Inc. SAVA 56.62 41.00 2.98 -12.42 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.20 47.00 1.00 -10.93 -9.59
SCYNEXIS, Inc. SCYX 48.95 0.00 10.28 -1.26 -30.84
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 46.90 9.00 8.75 -14.00 -36.08
Lipocine, Inc. LPCN 39.90 0.00 9.50 -2.66 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 25.88 0.00 -2.48 -2.74 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.80 3.00 2.59 -1.76 -264.21
Regulus Therapeutics, Inc. RGLS 17.49 0.00 1.54 -0.82 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.65 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.38 None 2.31 -0.62 None
VIVUS, Inc. VVUS 6.88 73.00 -0.15 -0.23 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.35 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 4.62 None 1.16 -0.10 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Mallinckrodt to Report Earnings Results for Second Quarter 2020

19h ago, source: PR Newswire

STAINES-UPON-THAMES, United Kingdom, July 9, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical ...

FDA Advisory Committee to Review Mallinckrodt'sTerlipressin

1d ago, source: YAHOO!

Mallinckrodt plc MNK announced that the Cardiovascular and Renal Drugs Advisory Committee of the FDA will hold a virtual meeting to review data on terlipressin. Terlipressin is an investigational ...

Mallinckrodt PLC

3d ago, source: Bloomberg

Mallinckrodt PLC develops, manufactures, and markets specialty pharmaceutical products and diagnostic imaging agents. The Company specializes in the manufacturing of pain management medications.

CRVS, HEPA Jump On COVID-19 Drug Bandwagon, LVGO In Good Health, NVAX Joins $100 Stock Price Club

1d ago, source: Business Insider

The Company is slated to report second-quarter financial results on August 5, 2020. Mallinckrodt plc's (MNK) Terlipressin, an investigational agent being evaluated for the treatment of hepatorenal ...

Analysts Anticipate Mallinckrodt PLC (NYSE:MNK) to Post $1.22 EPS

7d ago, source: theenterpriseleader.com

Brokerages forecast that Mallinckrodt PLC (NYSE:MNK) will announce earnings of $1.22 per share for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Mallinckrodt’s ...

BRIEF-Mallinckrodt Completes Rolling Submission Of Biologics License For Stratagraft Regenerative Skin Tissue To FDA

1mon ago, source: Reuters

MALLINCKRODT PLC - STRATAGRAFT SKIN TISSUE IS IN DEVELOPMENT AS POTENTIAL NEW TREATMENT OPTION FOR PATIENTS WITH DEEP PARTIAL-THICKNESS THERMAL BURNS * MALLINCKRODT PLC - STRATAGRAFT SKIN TISSUE ...

Mallinckrodt (NYSE:MNK) Upgraded by ValuEngine to Hold

6d ago, source: Stock Market Daily

Mallinckrodt stock has undergone multiple analysts rating changes in the recent past.  Mallinckrodt Upgraded by ValuEngine on ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.